- Home
- RCS vs BLDE Comparison
RCS vs BLDE Comparison
Compare RCS & BLDE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCS
- BLDE
- Stock Information
- Founded
- RCS 1994
- BLDE 2014
- Country
- RCS United States
- BLDE United States
- Employees
- RCS N/A
- BLDE N/A
- Industry
- RCS Investment Managers
- BLDE Aerospace
- Sector
- RCS Finance
- BLDE Consumer Discretionary
- Exchange
- RCS Nasdaq
- BLDE Nasdaq
- Market Cap
- RCS 292.8M
- BLDE 272.5M
- IPO Year
- RCS N/A
- BLDE N/A
- Fundamental
- Price
- RCS $6.32
- BLDE $3.18
- Analyst Decision
- RCS
- BLDE Strong Buy
- Analyst Count
- RCS 0
- BLDE 2
- Target Price
- RCS N/A
- BLDE $6.25
- AVG Volume (30 Days)
- RCS 141.1K
- BLDE 714.7K
- Earning Date
- RCS 01-01-0001
- BLDE 03-13-2025
- Dividend Yield
- RCS 10.12%
- BLDE N/A
- EPS Growth
- RCS N/A
- BLDE N/A
- EPS
- RCS N/A
- BLDE N/A
- Revenue
- RCS N/A
- BLDE $248,693,000.00
- Revenue This Year
- RCS N/A
- BLDE $5.29
- Revenue Next Year
- RCS N/A
- BLDE $8.99
- P/E Ratio
- RCS N/A
- BLDE N/A
- Revenue Growth
- RCS N/A
- BLDE 10.44
- 52 Week Low
- RCS $4.51
- BLDE $2.45
- 52 Week High
- RCS $6.31
- BLDE $5.17
- Technical
- Relative Strength Index (RSI)
- RCS 41.83
- BLDE 42.26
- Support Level
- RCS $6.21
- BLDE $2.81
- Resistance Level
- RCS $6.40
- BLDE $3.77
- Average True Range (ATR)
- RCS 0.14
- BLDE 0.23
- MACD
- RCS 0.01
- BLDE -0.01
- Stochastic Oscillator
- RCS 27.71
- BLDE 34.38
About RCS PIMCO Strategic Income Fund Inc.
PIMCO Strategic Income Fund, Inc. operates as a closed-end management investment company. Its primary investment objective is to generate a level of income that is higher than that generated by high-quality, intermediate-term U.S. debt securities. The Fund also seeks capital appreciation to the extent consistent with this objective.
About BLDE Blade Air Mobility Inc.
Blade Air Mobility Inc is a technology-powered air mobility platform that provides air transportation and logistics for hospitals and is a transporter of human organs for transplant, and for passengers, with helicopter and fixed-wing services predominantly in the Northeast United States, Southern Europe and Western Canada. The company's operating segments are; Passenger, and Medical. Majority of the revenue for the company is generated from its Medical segment which predominantly consists of transportation of human organs for transplant and the medical teams supporting these services. It also offers additional services including donor logistics coordination and support in evaluating potential donor organs. A substantial portion of the company's revenue is generated from the United States.